Chris Parker

Consultant Clinical Oncologist at The Royal Marsden

Chris qualified in medicine from Oxford University in 1989. He trained in oncology at the Royal Marsden Hospital, taking time out to work in Professor Colin Cooper’s lab at the Institute of Cancer Research. Following a clinical research fellowship at Princess Margaret Hospital in Toronto, since 2001 Chris has been a consultant clinical oncologist, specialising in prostate cancer, at the Royal Marsden. Alongside his clinical practice, he has led clinical trials testing the use of active surveillance for localised disease, post-operative radiation therapy for locally advanced disease and radium-223 for bone metastases. He is a former Chair of the National Cancer Research Institute Prostate Cancer Clinical Studies Group. He has published over 250 articles on prostate cancer.